Latest news on progress with UKAR

In November 2023 the UKAR Steering Committee hosted its autumn industry engagement meeting where progress with site and patient recruitment was shared. This was closely followed by a poster sharing progress to date at the BSAC Winter Conference and an opportunity for delegates to discuss UKAR with the study team.

As of November 2023 there were 9 sites actively recruiting, 22 sites in set-up phase and 15 sites exploring feasibility to join. Data collection was underway for 52 patients receiving 5 of the 11 study drugs.

Recruitment of sites is on track and patient recruitment growing as expected. The team is looking forward to sharing initial results in 2024.